Fidelity Investments’s Arbutus Biopharma ABUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$249K Buy
80,741
+2,732
+4% +$8.44K ﹤0.01% 3228
2025
Q1
$272K Buy
78,009
+101
+0.1% +$352 ﹤0.01% 3132
2024
Q4
$255K Sell
77,908
-5,372
-6% -$17.6K ﹤0.01% 3171
2024
Q3
$321K Sell
83,280
-17,538
-17% -$67.5K ﹤0.01% 3022
2024
Q2
$312K Sell
100,818
-65,024
-39% -$201K ﹤0.01% 2884
2024
Q1
$428K Buy
165,842
+498
+0.3% +$1.29K ﹤0.01% 2769
2023
Q4
$413K Sell
165,344
-10,795
-6% -$27K ﹤0.01% 2733
2023
Q3
$358K Sell
176,139
-8,766
-5% -$17.8K ﹤0.01% 2720
2023
Q2
$425K Sell
184,905
-1,812
-1% -$4.17K ﹤0.01% 2708
2023
Q1
$566K Buy
186,717
+1,509
+0.8% +$4.57K ﹤0.01% 2652
2022
Q4
$432K Sell
185,208
-1,568
-0.8% -$3.65K ﹤0.01% 2761
2022
Q3
$357K Buy
186,776
+23,469
+14% +$44.9K ﹤0.01% 2883
2022
Q2
$443K Sell
163,307
-823
-0.5% -$2.23K ﹤0.01% 2885
2022
Q1
$489K Buy
+164,130
New +$489K ﹤0.01% 2994
2021
Q3
Sell
-1
Closed 4259
2021
Q2
$0 Sell
1
-299
-100% ﹤0.01% 4166
2021
Q1
$1K Buy
+300
New +$1K ﹤0.01% 3786
2017
Q4
Sell
-19,200
Closed -$119K 2647
2017
Q3
$119K Hold
19,200
﹤0.01% 2577
2017
Q2
$69K Hold
19,200
﹤0.01% 2605
2017
Q1
$62K Hold
19,200
﹤0.01% 2636
2016
Q4
$47K Hold
19,200
﹤0.01% 2640
2016
Q3
$66K Hold
19,200
﹤0.01% 2640
2016
Q2
$67K Hold
19,200
﹤0.01% 2637
2016
Q1
$79K Hold
19,200
﹤0.01% 2646
2015
Q4
$85K Buy
19,200
+7,600
+66% +$33.6K ﹤0.01% 2712
2015
Q3
$71K Buy
+11,600
New +$71K ﹤0.01% 2703
2015
Q2
Sell
-11,600
Closed -$203K 2719
2015
Q1
$203K Buy
+11,600
New +$203K ﹤0.01% 2718